GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cathay Biotech 688065.SS · CNY

Materials · Shanghai · 🇨🇳 China

Compare

38.72

-0.79%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥3.30bn

FY2016FY2025

Net income

CN¥565.7m

FY2016FY2025

Free cash flow

−CN¥339.3m

FY2016FY2025

Shareholders' equity

CN¥21.22bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥3.30bnCN¥2.96bnCN¥2.11bnCN¥2.44bnCN¥2.36bnCN¥1.50bnCN¥1.92bnCN¥1.76bnCN¥1.36bnCN¥929.1m
Research and developmentCN¥237.9mCN¥233.3mCN¥189.1mCN¥187.7mCN¥133.5mCN¥84.3mCN¥90.2mCN¥86.4mCN¥64.6mCN¥37.5m
Operating incomeCN¥635.1mCN¥551.6mCN¥454.3mCN¥708.3mCN¥723.4mCN¥522.2mCN¥589.1mCN¥541.1mCN¥405.8mCN¥205.1m
Net incomeCN¥565.7mCN¥489.0mCN¥366.5mCN¥553.3mCN¥594.7mCN¥457.7mCN¥478.9mCN¥466.3mCN¥332.7mCN¥145.5m
Diluted earnings per share0.800.850.630.971.010.780.910.660.470.21

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥23.88bnCN¥19.02bnCN¥18.83bnCN¥17.83bnCN¥16.20bnCN¥12.14bnCN¥5.98bnCN¥4.84bnCN¥3.13bnCN¥1.66bn
Cash and short-term investmentsCN¥9.01bnCN¥5.35bnCN¥5.39bnCN¥6.30bnCN¥9.63bnCN¥7.04bnCN¥1.23bnCN¥242.8mCN¥135.1mCN¥349.6m
Total liabilities−CN¥21.22bnCN¥3.92bnCN¥4.06bnCN¥2.79bnCN¥1.51bnCN¥650.7mCN¥1.34bnCN¥1.68bnCN¥936.6mCN¥439.2m
Debt—CN¥1.90bnCN¥1.81bnCN¥1.13bnCN¥755.5m—CN¥307.0mCN¥386.0mCN¥170.0m—
Shareholders' equityCN¥21.22bnCN¥11.51bnCN¥11.16bnCN¥10.95bnCN¥10.67bnCN¥10.38bnCN¥4.64bnCN¥3.16bnCN¥2.20bnCN¥1.22bn
Shares outstanding708m573m583m572m591m584m527m708m708m708m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥404.1mCN¥820.9mCN¥569.5mCN¥803.7mCN¥594.2mCN¥515.0mCN¥359.6m−CN¥10.3mCN¥53.4m−CN¥128.7m
Capital spending−CN¥743.5m−CN¥843.3m−CN¥1.57bn−CN¥4.20bn−CN¥1.47bn−CN¥763.1m−CN¥511.1m−CN¥410.1m−CN¥995.1m−CN¥323.3m
Free cash flow−CN¥339.3m−CN¥22.4m−CN¥1.00bn−CN¥3.39bn−CN¥880.5m−CN¥248.1m−CN¥151.5m−CN¥420.4m−CN¥941.6m−CN¥452.0m
Dividends paid−CN¥313.1m−CN¥140.8m−CN¥104.8m−CN¥187.3m−CN¥333.3m−CN¥3.9m−CN¥121.3m−CN¥178.8m−CN¥95,000—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥1.03bnCN¥874.5mCN¥750.4mCN¥874.3mCN¥895.0mCN¥775.8mCN¥742.8mCN¥770.8m
Operating incomeCN¥227.2mCN¥215.6mCN¥128.1mCN¥161.2mCN¥184.1mCN¥161.7mCN¥162.5mCN¥108.6m
Net incomeCN¥207.0mCN¥165.7mCN¥115.0mCN¥142.0mCN¥171.7mCN¥137.0mCN¥143.8mCN¥97.7m
Diluted earnings per share0.290.230.160.200.240.190.250.17
Cash from operations———−CN¥66.0mCN¥251.0mCN¥87.0mCN¥144.0mCN¥240.0m
Capital spending−CN¥256.0m−CN¥295.0m−CN¥197.0m−CN¥187.0m−CN¥78.0m−CN¥279.0m−CN¥199.0m−CN¥79.0m
Free cash flow———−CN¥253.0mCN¥173.0m−CN¥192.0m−CN¥55.0mCN¥161.0m
Total assetsCN¥24.61bnCN¥24.56bnCN¥23.88bnCN¥23.45bnCN¥23.82bnCN¥24.69bnCN¥19.02bnCN¥18.33bn
Cash and short-term investments——CN¥9.01bnCN¥9.01bnCN¥9.82bnCN¥10.80bnCN¥5.35bnCN¥4.64bn
DebtCN¥377.5mCN¥303.4mCN¥189.0mCN¥81.5mCN¥543.1mCN¥1.64bnCN¥1.86bnCN¥1.26bn
Shareholders' equityCN¥17.76bnCN¥17.87bnCN¥21.22bnCN¥17.60bnCN¥17.45bnCN¥17.56bnCN¥11.51bnCN¥11.39bn

Financial ratios

Data as of 20 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin19.3%18.6%21.5%29.0%30.6%34.9%—
Net margin17.2%16.5%17.3%22.7%25.2%30.6%—
Return on equity2.7%4.2%3.3%5.1%5.6%4.4%—
Return on assets2.4%2.6%1.9%3.1%3.7%3.8%—
Free cash flow yield4.3%7.6%9.7%23.0%9.2%5.8%—
Revenue growth11.4%39.9%-13.4%3.3%57.9%-21.9%—
Earnings growth15.7%33.4%-33.8%-7.0%29.9%-4.4%—
Current ratio5.85x2.53x2.22x5.95x9.36x19.42x—
Debt to equity0.01x0.16x0.16x0.10x0.07x—0.06x
Equity ratio88.8%60.5%59.3%61.4%65.8%85.6%—
Interest coverage72.25x16.48x12.00x28.76x44.40x125.14x—
R&D as a share of sales7.2%7.9%8.9%7.7%5.6%5.6%—
Buybacks as a share of market value-23.6%1.7%-1.9%3.2%-1.2%-10.9%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue10.5%17.1%—
Operating income-3.6%4.0%—
Net income0.7%4.3%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings62.345.587.563.4130.877.5
Price to sales10.77.515.214.432.923.7

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 29 Jul 2026.

FY2026FY2025FY2024FY2023FY2022FY2021
Paid in the year0.450.400.190.180.450.571
  • 7-for-5 split · 20 Jul 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.